Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4

O Gorbenko1, G Panayotou, A Zhyvoloup

  • 1Department of Cell Signaling, Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine.

Insights

The phosphatase PTEN interacts with fatty acid-binding protein 4 (FABP4), suggesting a role in regulating lipid metabolism and adipocyte differentiation beyond its known tumor-suppressing functions.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • PTEN (Phosphatase and Tensin homolog) is a crucial tumor suppressor with dual phosphatase activity.
  • PTEN mutations are common in advanced cancers, and it's implicated in type II diabetes and obesity.
  • Understanding PTEN's broader cellular roles is essential for therapeutic development.

Purpose of the Study:

  • To identify novel PTEN-interacting proteins using yeast two-hybrid screening.
  • To investigate the functional significance of PTEN's interaction with adipocyte-specific fatty-acid-binding protein 4 (FABP4).
  • To elucidate PTEN's potential role in lipid metabolism and adipocyte differentiation.

Main Methods:

  • Yeast two-hybrid screening using the C-terminal PTEN sequence as bait.
  • Validation of positive clones via mating assays and DNA sequencing.
  • Co-immunoprecipitation, gel-filtration, and Biacore assays to study PTEN-FABP4 interaction kinetics.

Main Results:

  • Identified several PTEN-binding proteins, revealing connections to diverse signaling pathways.
  • Confirmed a significant interaction between PTEN and FABP4.
  • Quantified the dissociation constant (K(D)) of the PTEN-FABP4 complex at approximately 2.8 microM.

Conclusions:

  • PTEN participates in cellular functions beyond tumor suppression, potentially involving lipid metabolism.
  • The interaction between PTEN and FABP4 highlights a novel regulatory mechanism in adipocyte biology.
  • PTEN's role in lipid metabolism warrants further investigation for therapeutic applications in metabolic diseases.

Related Concept Videos

Lipids as Anchors01:32

Lipids as Anchors

In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...